Evidence review
Evidence
Review and download supporting evidence. Includes the full guideline if available.
Supporting evidence
-
-
-
-
-
B: Continuous glucose monitoring in children and young people with type 1 diabetes (PDF 1.95 MB)
-
A: Fluid therapy for the management of diabetic ketoacidosis (PDF 1.93 MB)
-
Surveillance report
-
-
Appendix A: NICE guideline recommendations and the evidence underlying them (PDF 334 KB)
-
-
Appendix A: Drugs included in the 2021 focussed evidence search (PDF 136 KB)
-
2019 surveillance of diabetes (NICE guidelines NG17, NG18, NG19 and NG28)
-
Appendix A1: Summary of evidence from surveillance (NG17) (PDF 1.2 MB)
-
Appendix B1: Stakeholder consultation comments table (NG17) (PDF 1.38 MB)
-
Appendix A2: Summary of evidence from surveillance (NG28) (PDF 1.86 MB)
-
Appendix B2: Stakeholder consultation comments table (NG28) (PDF 1.86 MB)
-
Appendix A3: Summary of evidence from surveillance (NG18) (PDF 992 KB)
-
Appendix B3: Stakeholder consultation comments table (NG18) (PDF 1.26 MB)
-
Appendix A4: Summary of evidence from surveillance (NG19) (PDF 746 KB)
-
Appendix B4: Stakeholder consultation comments table (NG19) (PDF 1.04 MB)
-
Full guidance
-
-
-